tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
US Market
CRNX
Crinetics Pharmaceuticals
RESEARCH TOOLSreports

Crinetics Pharmaceuticals (CRNX) Stock News & Sentiment

Compare
752 Followers
‘Markets Climb Wall-of-Worry’: Oppenheimer Sees Resilience Driving 2026 and Suggests 2 Stocks to Buy
Premium
Stock Analysis & Ideas
‘Markets Climb Wall-of-Worry’: Oppenheimer Sees Resilience Driving 2026 and Suggests 2 Stocks to Buy
3d ago
AMPX
CRNX
Crinetics Highlights Breakout Year and Strong Endocrinology Pipeline
Premium
Company Announcements
Crinetics Highlights Breakout Year and Strong Endocrinology Pipeline
6d ago
8K
CRNX
Crinetics Pharmaceuticals: Phase 2 TouCAHn De‑Risking and Optimized Phase 3 Design Drive Upgrade to Buy and $67 Target
Premium
Ratings
Crinetics Pharmaceuticals: Phase 2 TouCAHn De‑Risking and Optimized Phase 3 Design Drive Upgrade to Buy and $67 Target
7d ago
CRNX
Crinetics Announces Major Public Offering to Fund Growth
Premium
Company Announcements
Crinetics Announces Major Public Offering to Fund Growth
12d ago
8K
CRNX
Crinetics Highlights Strong PALSONIFY Launch and Trial Progress
Premium
Company Announcements
Crinetics Highlights Strong PALSONIFY Launch and Trial Progress
14d ago
8K
CRNX
Crinetics Buy Rating: Derisked Atumelnant CAH Program and Outperforming Palsonify Launch Signal Undervalued Shares
Premium
Ratings
Crinetics Buy Rating: Derisked Atumelnant CAH Program and Outperforming Palsonify Launch Signal Undervalued Shares
14d ago
CRNX
Crinetics (CRNX): Robust Atumelnant CAH Data, De-Risked Phase 3, and Strong Execution Underpin Buy Rating
Premium
Ratings
Crinetics (CRNX): Robust Atumelnant CAH Data, De-Risked Phase 3, and Strong Execution Underpin Buy Rating
14d ago
CRNX
More CRNX News >

CRNX News on the Web

Analysts’ Top Healthcare Picks: Crinetics Pharmaceuticals (CRNX), Denali Therapeutics (DNLI)
TipRanks News
Neutral
Crinetics Pharmaceuticals Raises $350 Million Through Public Offering—Focus on Endocrine Disease Innovation and Product Launch
Market Chameleon
Neutral
Crinetics Pharmaceuticals Announces $350 Million Equity Offering to Power Paltusotine Launch and R&D Pipeline
Market Chameleon
Neutral
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX) and Exact Sciences (EXAS)
TipRanks News
Neutral
RBC Capital would be a buyer of Neurocrine on weakness following competitor data
The Fly
Neutral
Crinetics to Reveal Topline Results from Key Atumelnant Trial as Investors Eye Pipeline Progress
Market Chameleon
Neutral
Crinetics to Announce Phase 2 Cohort Results for Atumelnant and Share PALSONIFY Business Update—What Does This Mean for Endocrine Disease Treatment?
Market Chameleon
Neutral
Crinetics To Provide Update On PALSONIFY And Topline Results From Phase 2 Trial Of Atumelnant In CAH
rttnews
Neutral

News Score - Last 7 Days

Neutral
CRNX
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.25 articles
News Sentiment
This Week50%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CRNX’s Media Buzz Sentiment?
1 articles about CRNX were published this week. In an average week, 2.25 articles are published.
    What is CRNX’s weekly average amount of articles?
    In an average week, 2.25 articles about CRNX are published.
      What is CRNX’s News Sentiment?
      50% of articles about CRNX were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        CAHCardinal Health
        ALKSAlkermes
        WSTWest Pharmaceutical Services
        AGENAgenus
        PENPenumbra
        Showing the stocks with the most bullish news sentiment over the past week